Four Component Meningococcal Capsular Group B Vaccine in Preterm Infants

被引:3
|
作者
Sadarangani, Manish [1 ,2 ,3 ,4 ]
Barlow, Sheula [2 ,3 ,4 ]
Anthony, Mark [4 ]
Pollard, Andrew J. [2 ,3 ,4 ]
机构
[1] Univ British Columbia, BC Childrens Hosp, Res Inst, Vaccine Evaluat Ctr, Vancouver, BC, Canada
[2] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England
[3] NIHR Oxford Biomed Res Ctr, Oxford, England
[4] Oxford Univ Hosp NHS Fdn Trust, Dept Paediat, Oxford, England
关键词
ROUTINE INFANT; IMMUNOGENICITY; VACCINATIONS; IMMUNIZATION; RECOMBINANT;
D O I
10.1093/jpids/pix013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:309 / 310
页数:2
相关论文
共 50 条
  • [1] Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants
    Pinto, Marta Valente
    O'Connor, Daniel
    Galal, Ushma
    Clutterbuck, Elizabeth A.
    Robinson, Hannah
    Plested, Emma
    Bibi, Sagida
    Pellisso, Susana Camara
    Hughes, Harri
    Kerridge, Simon
    Mujadidi, Yama F.
    Findlow, Helen
    Borrow, Ray
    Snape, Matthew D.
    Pollard, Andrew J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [3] CURRENT STATUS OF MENINGOCOCCAL GROUP-B VACCINE CANDIDATES - CAPSULAR OR NONCAPSULAR
    ROMERO, JD
    OUTSCHOORN, IM
    CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (04) : 559 - &
  • [4] An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants
    Calvert, Anna
    Andrews, Nick
    Barlow, Sheula
    Borrow, Ray
    Black, Charlotte
    Bromage, Barbara
    Carr, Jeremy
    Clarke, Paul
    Collinson, Andrew C.
    Few, Karen
    Hayward, Naomi
    Jones, Christine E.
    Le Doare, Kirsty
    Ladhani, Shamez N.
    Louth, Jennifer
    Papadopoulou, Georgia
    Pople, Michelle
    Scorrer, Tim
    Snape, Matthew D.
    Heath, Paul T.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2024, 109 (11) : 898 - 904
  • [5] Prevention of serogroup B meningococcal disease using a four-component vaccine
    Gil, A.
    Barranco, D.
    Batalla, J.
    Bayas, J. M.
    Campins, M.
    Gorrotxategi Gorrotxategi, P.
    Lluch, J.
    Martinon-Torres, F.
    Mellado, M. J.
    Moreno-Perez, D.
    Uriel, B.
    Vazquez, J. A.
    ANALES DE PEDIATRIA, 2014, 80 (04): : 259 - 260
  • [6] Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers
    Findlow, Jamie
    Bai, Xilian
    Findlow, Helen
    Newton, Emma
    Kaczmarski, Ed
    Miller, Elizabeth
    Borrow, Ray
    VACCINE, 2015, 33 (29) : 3322 - 3330
  • [7] Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
    Ladhani, Shamez N.
    Andrews, Nick
    Parikh, Sydel R.
    Campbell, Helen
    White, Joanne
    Edelstein, Michael
    Bai, Xilian
    Lucidarme, Jay
    Borrow, Ray
    Ramsay, Mary E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04): : 309 - 317
  • [8] The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy
    Rollier, Christine S.
    Dold, Christina
    Marsay, Leanne
    Sadarangani, Manish
    Pollard, Andrew J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (01) : 131 - 142
  • [9] An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
    Dold, Christina
    Marsay, Leanne
    Wang, Nelson
    Silva-Reyes, Laura
    Clutterbuck, Elizabeth
    Paterson, Gavin K.
    Sharkey, Kelsey
    Wyllie, David
    Beernink, Peter T.
    Hill, Adrian V.
    Pollard, Andrew J.
    Rollier, Christine S.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (701)
  • [10] From a pathogen's genome to an effective vaccine: the four-component meningococcal serogroup B vaccine
    Abad, Raquel
    Martinon-Torres, Federico
    Elena Santolaya, Maria
    Banzhoff, Angelika
    Gonzalez-Inchausti, Carmen
    Gabriela Grana, Maria
    Vazquez, Julio A.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (03) : 208 - 216